Advanced Search
ZHAO Ting, ZHANG Fang-fei, WANG Nian-song, et al. Research progress of NLRP3 inflammasome as a potential therapeutic target for kidney disease[J]. Chin J Clin Med, 2022, 29(4): 685-695. DOI: 10.12025/j.issn.1008-6358.2022.20210133
Citation: ZHAO Ting, ZHANG Fang-fei, WANG Nian-song, et al. Research progress of NLRP3 inflammasome as a potential therapeutic target for kidney disease[J]. Chin J Clin Med, 2022, 29(4): 685-695. DOI: 10.12025/j.issn.1008-6358.2022.20210133

Research progress of NLRP3 inflammasome as a potential therapeutic target for kidney disease

  • Plenty of evidence suggested an association between kidney disease and inflammasomes, especially nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasomes. NLRP3 inflammasomes play an important role in renal inflammation and fibrosis. Small molecule inhibitors targeting the components of NLRP3 inflammasomes are potential options for the treatment of kidney-related diseases. This article reviews the new findings of the role of NLRP3 inflammasomes in kidney disease in recent years and new strategies targeting NLRP3 inflammasomes.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return